This site is intended for healthcare professionals
News

FDA approves Tecentriq + Cotellic + Zelboraf to treat of BRAF V600 mutation-positive advanced melanoma patients.- Genentech/Roche

Read time: 1 mins
Last updated:3rd Aug 2020
Published:1st Aug 2020
Condition: Metastatic Melanoma
Type: drug
Register free for full access to medthority.com